Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

INTERVENTIONALInicio: 25 de mar de 2022ID: NCT04928846

ReclutandoFase 3ClinicalTrials.gov

A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis

INTERVENTIONALInicio: 7 de nov de 2024ID: NCT06632457

ReclutandoFase 2ClinicalTrials.gov

A Phase 1b/2 Open-Label Clinical Study to Evaluate the Safety and Efficacy of MK-6070 and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer

INTERVENTIONALInicio: 27 de feb de 2025ID: NCT06780137

ReclutandoClinicalTrials.gov

Longitudinal Early-onset Alzheimer's Disease Study Protocol

OBSERVATIONALInicio: 30 de abr de 2018ID: NCT03507257

ReclutandoClinicalTrials.gov

A Prospective, Observational Study to Assess the Real-World Usage and Outcomes of HyQvia in Patients With Multiple Myeloma (MM) Diagnosed With Secondary Immunodeficiency (SID)

OBSERVATIONALInicio: 17 de oct de 2023ID: NCT05879757

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients With PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)

INTERVENTIONALInicio: 10 de abr de 2025ID: NCT06868277

ReclutandoFase 3ClinicalTrials.gov

A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis Stages F2 and F3

INTERVENTIONALInicio: 19 de ago de 2021ID: NCT04849728

ReclutandoFase 1ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Non-arteritic Ischemic Optic Neuropathy

INTERVENTIONALInicio: 1 de feb de 2022ID: NCT05147701

ReclutandoClinicalTrials.gov

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery: An International, Randomized Superiority Trial (OPBC-10/ NOAX)

INTERVENTIONALInicio: 1 de ene de 2026ID: NCT07140172

ReclutandoFase 3ClinicalTrials.gov

A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

INTERVENTIONALInicio: 20 de nov de 2024ID: NCT06532656

ReclutandoFase 2ClinicalTrials.gov

A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia

INTERVENTIONALInicio: 16 de dic de 2024ID: NCT06721156

ReclutandoFase 2ClinicalTrials.gov

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Interventions for Chronic Weight Management in Adult Participants With Obesity or Overweight

INTERVENTIONALInicio: 17 de nov de 2023ID: NCT06143956

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults With High-Grade Non-Muscle Invasive Bladder Cancer

INTERVENTIONALInicio: 15 de sept de 2023ID: NCT05951179

ReclutandoClinicalTrials.gov

Proof-of-concept Case-control Study for Colorectal Cancer Assessment Using Delta-HLD Technology (CASCADE)

OBSERVATIONALInicio: 30 de jun de 2021ID: NCT07148297

ReclutandoClinicalTrials.gov

Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait. A Multi-center Prospective Randomized Controlled Trial. (CCHOWW)

INTERVENTIONALInicio: 14 de jul de 2021ID: NCT05000697

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease

INTERVENTIONALInicio: 12 de may de 2025ID: NCT06819891

ReclutandoClinicalTrials.gov

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

OBSERVATIONALInicio: 2 de ene de 2024ID: NCT07159750

ReclutandoFase 2ClinicalTrials.gov

An Adaptive, Randomized, Double-blind, Dose Exploration, Parallel Group, Placebo Controlled, Multicenter Phase 2 Trial to Evaluate the Efficacy, Safety and Tolerability of LNP023 in Combination With Standard-of-care With and Without Oral Corticosteroids in Patients With Active Lupus Nephritis Class III-IV, +/- V

INTERVENTIONALInicio: 10 de ago de 2022ID: NCT05268289

ReclutandoFase 2ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled, Four-arm, Parallel-group, Dose-finding Phase 2b Study to Investigate the Safety and Efficacy of TIN816 Via a Single Intravenous Infusion in the Treatment of Participants With Sepsis-associated Acute Kidney Injury (CLEAR-AKI)

INTERVENTIONALInicio: 18 de ene de 2024ID: NCT05996835

ReclutandoFase 3ClinicalTrials.gov

Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine

INTERVENTIONALInicio: 8 de jun de 2023ID: NCT05897320